<DOC>
	<DOCNO>NCT01239979</DOCNO>
	<brief_summary>The investigator seek assess whether plasma myeloperoxidase ( MPO ) level differ among patient stable unstable CAD patient control subject , correlate inflammatory clinical risk factor ox-LDL , NO , leptin , adiponectin , sPLA2 , Lp-PLA2 , homocysteine 3-nitrotyrosine patient .</brief_summary>
	<brief_title>Plasma Myeloperoxidase Levels Patients With Coronary Artery Disease</brief_title>
	<detailed_description>Elevation leukocyte enzyme myeloperoxidase ( MPO ) stable coronary artery disease ( CAD ) patient contrast unstable CAD patient controversial relationship inflammatory noninflammatory marker oxidize LDL ( ox-LDL ) nitric oxide ( NO ) CAD patient evaluate yet . Evaluation relationship aim study.Also relationship MPO inflammatory biomarker leptin , adiponectin , sPLA2 , Lp-PLA2 , homocysteine 3-nitrotyrosine examine . This study include 50 stable CAD , 50 unstable CAD patient 50 control . Plasma MPO , ox-LDL , leptin , adiponectin , sPLA2 level determine use enzyme immunoassay.Homocysteine 3-nitrotyrosine measure use HPLC-fluorescence method . Plasma total NO risk factor lipid profile , hypertension , smoking , diabetes mellitus familial history CAD also determine patient . Results statistically analyse association marker assess .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Stable unstable patient angiographically document coronary artery disease . Control subject without angiographically document coronary artery disease . All subject Patients recent ( 6 month ) myocardial infarction cardiovascular event , surgery ( 3 month ) , cancer infective inflammatory disease include study .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>coronary artery disease</keyword>
</DOC>